MLKL and nonpapillary renal cell carcinoma: While in VHL-deficient ccRCC, Tang et al. found that inhibitors of SLC7A11 (sulfasalazine) triggered mixed-lineage kinase domain-like protein (MLKL)-mediated necroptosis [29].